Gender Dysphoria: Clinical Trials

2 trials for Gender Dysphoria, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Completed 2
Phase 21Completed 1

Follow Gender Dysphoria: new trials by email Literature Review of Gender Dysphoria trials Research Report on Gender Dysphoria

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluating Drug Interactions Between Doravirine With Estradiol and Spironolactone in Healthy Transgender Women
Doravirine/Lamivudine/Tenofovir, Spironolactone 100mg, Estradiol 2mg - Transgender Health, Gender Dysphoria
Phase 1CompletedThomas Jefferson University82022-01-042025-03-26
Subcutaneous Testosterone Project
Subcutaneous testosterone - Gender Dysphoria
Phase 1 / Phase 2CompletedUniversity of British Columbia142015-07-012016-06-06

Narrower conditions

Acquired Immunodeficiency Syndrome (1)

Broader conditions

Mental Disorders (2)  ·  Sexual Dysfunctions, Psychological (2)  ·  Blood-Borne Infections (1)  ·  Communicable Diseases (1)  ·  Genital Diseases (1)  ·  HIV Infections (1)  ·  Immune System Diseases (1)  ·  Immunologic Deficiency Syndromes (1)  ·  Infections (1)  ·  Lentivirus Infections (1)  ·  RNA Virus Infections (1)  ·  Retroviridae Infections (1)  ·  Sexually Transmitted Diseases (1)  ·  Sexually Transmitted Diseases, Viral (1)  ·  Slow Virus Diseases (1)

Interventions

Canrenoic Acid (1)  ·  Estradiol (1)  ·  Spironolactone (1)  ·  doravirine (1)  ·  testosterone 17 beta-cypionate (1)

Sponsors

Thomas Jefferson University (1)  ·  University of British Columbia (1)

Countries

Canada (1)  ·  United States (1)

Top investigators

Mary Ensom, Pharm D/PhD (1)  ·  Walter K Kraft, MD (1)

Results publications

PMID 38421210